The Journal of Immunology · 2007 · 225 citations · 15 references
Life SciencesImmunologyPathologyImmunoregulationInflammationSignal TransductionCytokine BiologyImmune Cell SignalingImmune RegulationInflammatory Bowel DiseaseRegulatory T CellsT Cell BiologyCd4 Positive T CellsChronic Inflammatory Disease ModelsInflammatory Bowel Disease ImmunopathogenesisMurine ModelsT Cell-mediated InflammationT-cell Mediated InflammationTransgenic Mice
Chronic inflammatory diseases may develop when regulatory T cells (Tregs) fail to control the balance between tolerance and immunity. Alternatively, activated immune cells might prevent the induction or activation of Tregs in such diseases. In this study, we demonstrate that trans-signaling into T cells via the soluble IL-6 receptor completely abrogates the de novo induction of adaptive Tregs. Mechanistically, IL-6 trans-signaling augmented the expression of the TGF-beta signaling inhibitor SMAD7. Consequently, SMAD7 overexpression in T cells using newly created transgenic mice rendered CD4(+)CD25(-) T cells resistant to the induction of FoxP3. Finally, IL-6 trans-signaling inhibited Treg-mediated suppression in a murine model of colitis. In summary, IL-6 trans-signaling into T cells emerges as a key pathway for blockade of the development of adaptive Tregs and thus may play a pivotal role in shifting the balance between effector and regulatory T cell numbers in chronic inflammatory and autoimmune diseases.
15
WanJun Chen, Wenwen Jin, Neil J. Hardegen et al. · The Journal of Experimental Medicine · 2003 · 4.6K citations · Full text
Raja Atreya, Jonas Mudter, Susetta Finotto et al. · Nature Medicine · 2000 · 1.3K citations
Life Sciences, Immunology, Pathology +17